From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
June 9, 2015
Philadelphia, PA – June 9, 2015 – IntegriChain, a rapidly growing cloud company focused on channel management for healthcare suppliers, today announced the availability of a free ebook for healthcare manufacturers on best practices for incorporating downstream inventory into gross-to-net accounting practices. This ebook focuses on the issues that impact common methodologies for estimating the total value of channel inventory. It also presents best practices to avoid error risk in calculating the impact of downstream (retail) inventory on gross-to-net as well as practical use cases. The ebook is available for download here.
“Most healthcare manufacturers utilize 852 data to estimate inventory, but these data only reveal 40% to 60% of the complete inventory picture,” said Josh Halpern, Co-Founder and Executive Vice President of IntegriChain. “This represents far too much risk in setting total pipeline reserves – critical to every gross-to-net accounting process. Healthcare manufacturers and their auditors require a complete view of inventory, including inventory for any NDC distributed in the downstream pipeline, across all channels of business. This ebook explains how to achieve that complete picture to de-risk the process of estimating inventory, creating reporting consistency and reliability for reserve management, loss of exclusivity and launch reserve tracking and planning, budget and production cycle planning, and forecasting inventory movements and trends.”
This ebook explains how to achieve that complete picture to de-risk the process of estimating inventory, creating reporting consistency and reliability for reserve management, loss of exclusivity and launch reserve tracking and planning, budget and production cycle planning, and forecasting inventory movements and trends.
“Depending on a product’s lifecycle, gross-to-net components such as returns reserves can be difficult to predict accurately,” said Shivani Patel, IntegriChain’s Director of Advanced Analytics, who is responsible for the company’s advanced modeling services. “This ebook is ideal for financial analysts, controllers, and gross-to-net analysts in healthcare manufacturers as well as their audit partners who seek to increase the precision of gross-to-net calculations.”
About IntegriChain IntegriChain is the leading channel management cloud used by healthcare suppliers, including nine of the top-10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than $200 billion in annual US commerce and 2.0 billion transactions flowed through the IntegriChain Cloud in 2014. For more information, visit www.integrichain.com and follow us on Twitter @IntegriChain.
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contacts Jennifer Guinan | Sage Strategic Marketing 610.410.8111 Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
